Recent advances in antimalarial drug development.

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar, Punjab 160 062, India.
Medicinal Research Reviews (Impact Factor: 9.58). 02/2007; 27(1):65-107. DOI: 10.1002/med.20062
Source: PubMed

ABSTRACT Malaria caused by protozoa of the genus Plasmodium, because of its prevalence, virulence, and drug resistance, is the most serious and widespread parasitic disease encountered by mankind. The inadequate armory of drugs in widespread use for the treatment of malaria, development of strains resistant to commonly used drugs such as chloroquine, and the lack of affordable new drugs are the limiting factors in the fight against malaria. These factors underscore the continuing need of research for new classes of antimalarial agents, and a re-examination of the existing antimalarial drugs that may be effective against resistant strains. This review provides an in-depth look at the most significant progress made during the past 10 years in antimalarial drug development.

  • [Show abstract] [Hide abstract]
    ABSTRACT: In a bid to come up with effective natural plant product-based antagonist in antimalarial chemotherapy, we have built an in-house library of 185 compounds. The binding site of Plasmodium wild-type DHFR (1J3I) was explored computationally using AutoDock. The top-screened compounds revealed some novel scaffolds, relative to the general folate template, with micromolar to nanomolar inhibition constants. Further structural optimization subjected to the actual synthesis of these inhibitors can improve their efficacy as better candidates in the drug design pipeline.
    Medicinal Chemistry Research 01/2014; · 1.61 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Current malaria therapeutics demands strategies able to selectively deliver drugs to Plasmodium-infected red blood cells (pRBCs) in order to limit the appearance of parasite resistance. Here, the poly(amidoamines) AGMA1 and ISA23 have been explored for the delivery of antimalarial drugs to pRBCs. AGMA1 has antimalarial activity per se as shown by its inhibition of the in vitro growth of P. falciparum, with an IC50 of 13.7μM. Fluorescence-assisted cell sorting data and confocal fluorescence microscopy and transmission electron microscopy images indicate that both polymers exhibit preferential binding to and internalization into pRBCs vs. RBCs, and subcellular targeting to the parasite itself in widely diverging species such as P. falciparum and P. yoelii, infecting humans and mice respectively. AGMA1 and ISA23 polymers with hydrodynamic radii around 7nm show a high loading capacity for the antimalarial drugs primaquine and chloroquine, with the final conjugate containing from 14.2 to 32.9% (w/w) active principle. Intraperitoneal administration of 0.8mg/kg chloroquine as either AGMA1 or ISA23 salts cured P. yoelii-infected mice, whereas control animals treated with twice as much free drug did not survive. These polymers combining into a single chemical structure drug carrying capacity, low unspecific toxicity, high biodegradability, and selective internalization into pRBCs but not in healthy erythrocytes for human and rodent malarias, may be regarded as promising candidates deserving to enter the antimalarial therapeutic arena.
    Journal of Controlled Release 01/2014; · 7.63 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The present review describes the current status of synthetic five and six-membered cyclic peroxides such as 1,2-dioxolanes, 1,2,4-trioxolanes (ozonides), 1,2-dioxanes, 1,2-dioxenes, 1,2,4-trioxanes, and 1,2,4,5-tetraoxanes. The literature from 2000 onwards is surveyed to provide an update on synthesis of cyclic peroxides. The indicated period of time is, on the whole, characterized by the development of new efficient and scale-up methods for the preparation of these cyclic compounds. It was shown that cyclic peroxides remain unchanged throughout the course of a wide range of fundamental organic reactions. Due to these properties, the molecular structures can be greatly modified to give peroxide ring-retaining products. The chemistry of cyclic peroxides has attracted considerable attention, because these compounds are used in medicine for the design of antimalarial, antihelminthic, and antitumor agents.
    Beilstein Journal of Organic Chemistry 01/2014; 10:34-114. · 2.80 Impact Factor